Effectiveness of Risk-Adapted Upper Gastrointestinal Cancer Screening in China: Prospective Cohort Study
JMIR Public Health and Surveillance · 2024
DOI: 10.2196/62864 ↗At a glance
Kohortenstudie in JMIR Public Health and Surveillance, 2024. Written by Youqing Wang and 7 co-authors. Institution: Department of Cancer Prevention, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China. Major MEDLINE topics: Gastrointestinal Neoplasms, Early Detection of Cancer. Cited 6 times so far (Crossref); 32 references. The full text is freely available in PubMed Central.
Abstract (original language)
Background
Previous studies have proved the effectiveness of endoscopic screening in rural areas; however, long-term, high-quality evidence regarding the effectiveness of risk-adapted upper gastrointestinal cancer (UGC) sequential screening strategies in resource-rich regions is currently lacking.
Objective
The objectives were to validate the effectiveness of risk-adapted sequential screening strategies in UGC prevention and control and assess the potential of sequential screening to lower mortality rates.
Methods
Based on the Cancer Screening Program in Urban China, a prospective, large-scale cohort study based on population was conducted to recruit individuals from 4 cities in China from 2013‐2019. Those identified as having a high risk of UGC according to a validated risk-score model were advised to undergo endoscopy tests. Follow-up outcomes were tracked until June 2021. Incidence of UGC, UGC-related mortality, and all-cause mortality were evaluated between the screened and nonscreened cohorts.
Results
The study included 153,079 participants at baseline. In total, 113,916 (74.42%) of the participants were designated as low risk of UGC. The remaining 39,163 (25.68%) participants were deemed to be at high risk of UGC and were offered gastroscopy tests. Among the high-risk participants, 9627 (compliance rate 24.6%) adhered to the gastroscopy tests. Over a median follow-up of 6.05 (IQR 3.06‐7.06) years, 622 UGC cases, 180 UGC deaths, and 1958 all-cause death cases were traced. The screened cohort exhibited the highest cumulative incidence of UGC (119.2 per 100,000 person-years), followed by the nonscreened and low-risk cohorts. Obvious reductions in both all-cause mortality and UGC mortality were observed between those who undertook screening (153.7 and 4.7 per 100,000 person-years, respectively) and the nonscreened group (245.3 and 27 per 100,000 person-years, respectively). The screening population showed a significant 36% and 82% reduction in both all-cause mortality (hazard ratio [HR] 0.64, 95% CI 0.49‐0.83, P .05).
Conclusions
Our study suggests the significance of one-off risk-adapted UGC screening in reducing both all-cause mortality and UGC mortality, particularly among high-risk individuals, indicating its effectiveness in UGC prevention and management.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Cancer Prevention, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China.
- Department of Endoscopy, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China.
ORCID profiles: Youqing Wang, Juan Zhu, Huizhang Li, Le Wang, Chen Zhu, Xue Li, Shi Wang, Lingbin Du
Cite
APA
Wang, Y., Zhu, J., Li, H., Wang, L., Zhu, C., Li, X., Wang, S., & Du, L. (2024). Effectiveness of Risk-Adapted Upper Gastrointestinal Cancer Screening in China: Prospective Cohort Study. JMIR Public Health and Surveillance. https://doi.org/10.2196/62864
Vancouver
Wang Y, Zhu J, Li H, Wang L, Zhu C, Li X, et al. Effectiveness of Risk-Adapted Upper Gastrointestinal Cancer Screening in China: Prospective Cohort Study. JMIR Public Health and Surveillance. 2024. doi:10.2196/62864
BibTeX
@article{Wang2024,
author = {Wang, Youqing and Zhu, Juan and Li, Huizhang and Wang, Le and Zhu, Chen and Li, Xue and Wang, Shi and Du, Lingbin},
title = {Effectiveness of Risk-Adapted Upper Gastrointestinal Cancer Screening in China: Prospective Cohort Study},
journal = {JMIR Public Health and Surveillance},
year = {2024},
doi = {10.2196/62864}
}
EUVIMED